Facial Plast Surg 2004; 20(2): 117-123
DOI: 10.1055/s-2004-861751
Copyright © 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001 USA.

Collagen Fillers in Facial Aesthetic Surgery

Raymond S. Douglas1 , 2 , 3 , Irene Donsoff4 , Todd Cook3 , Norman Shorr1 , 3
  • 1Shorr-Douglas FACE Institute, Beverly Hills, California
  • 2Department of Orbital and Ophthalmic Plastic Surgery, Greater Los Angeles Veterans Hospital, Los Angeles, California
  • 3Department of Ophthalmology, Jules Stein Eye Institute, UCLA, Los Angeles, California
  • 4Private Practice, New York, New York
Further Information

Publication History

Publication Date:
11 January 2005 (online)

ABSTRACT

The search for an ideal facial augmentation agent continues. Patient evaluation, choice of augmentation agent, and injection technique are discussed.

REFERENCES

  • 1 Skouge J, Diwan R. Soft tissue augmentation with injectable collagen. In: Papel I, Nachlas N Facial Plastic and Reconstructive Surgery St Louis; Mosby Year Book 1992: 203-212
  • 2 Clark D P, Hanke C W, Swanson N A. Dermal implants: safety of products injected for soft tissue augmentation.  J Am Acad Dermatol. 1989;  21(5 Pt 1) 992-998
  • 3 Burgess L P, Goode R L. Injectable collagen.  Facial Plast Surg. 1992;  8 176-182
  • 4 Pollack S V. Silicone, fibrel, and collagen implantation for facial lines and wrinkles.  J Dermatol Surg Oncol. 1990;  16 957-961
  • 5 DeLustro F, Smith S T, Sundsmo J et al.. Reaction to injectionable collagen: results in animal models and clinical use.  Plast Reconstr Surg. 1987;  4 581-589
  • 6 Fagien S. Facial soft-tissue augmentation with injectable autologous and allogeneic human tissue collagen matrix (autologen and dermalogen). Plast Reconstr Surg 2000 105: 362-373 (discussion 74-75)
  • 7 Sclafani A P, Romo III T, Parker A et al.. Autologous collagen dispersion (Autologen) as a dermal filler: clinical observations and histologic findings.  Arch Facial Plast Surg. 2000;  2 48-52
  • 8 Engstrom-Laurent A. Hyaluronan in joint disease.  J Intern Med. 1997;  242 57-60
  • 9 Lee J Y, Spicer A P. Hyaluronan: a multifunctional, megaDalton, stealth molecule.  Curr Opin Cell Biol. 2000;  12 581-586
  • 10 Sutherland I W. Novel and established applications of microbial polysaccharides.  Trends Biotechnol. 1998;  16 41-46
  • 11 Laurent T C, Fraser J R. Hyaluronan.  FASEB J. 1992;  6 2397-2404
  • 12 Goa K L, Benfield P. Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing.  Drugs. 1994;  47 536-566
  • 13 Kumari K, Weigel P H. Molecular cloning, expression, and characterization of the authentic hyaluronan synthase from group C Streptococcus equisimilis.  J Biol Chem. 1997;  272 32539-32546
  • 14 Piacquadio D. Crosslinked hyaluronic acid (hylan gel) as a soft tissue augmentation material: a preliminary assessment. In: Elson M Evaluation and Treatment of the Aging Face New York; Springer-Verlag 1994: 174-178
  • 15 Piacquadio D, Jarcho M, Goltz R. Evaluation of hylan b gel as a soft-tissue augmentation implant material.  J Am Acad Dermatol. 1997;  36 544-549
  • 16 Olenius M. The first clinical study using a new biodegradable implant for the treatment of lips, wrinkles, and folds.  Aesthetic Plast Surg. 1998;  22 97-101
  • 17 Duranti F, Salti G, Bovani B et al.. Injectable hyaluronic acid gel for soft tissue augmentation. A clinical and histological study.  Dermatol Surg. 1998;  24 1317-1325
  • 18 Lowe N J, Maxwell C A, Lowe P et al.. Hyaluronic acid skin fillers: adverse reactions and skin testing.  J Am Acad Dermatol. 2001;  45 930-933
  • 19 Micheels P. Human anti-hyaluronic acid antibodies: is it possible?.  Dermatol Surg. 2001;  27 185-191
  • 20 Shafir R, Amir A, Gur E. Long-term complications of facial injections with Restylane (injectable hyaluronic acid).  Plast Reconstr Surg. 2000;  106 1215-1216
  • 21 Kavouni A, Stanec J J. Human antihyaluronic acid antibodies.  Dermatol Surg. 2002;  28 359-360
  • 22 Lupton J R, Alster T S. Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel.  Dermatol Surg. 2000;  26 135-137
  • 23 Schanz S, Schippert W, Ulmer A et al.. Arterial embolization caused by injection of hyaluronic acid (Restylane).  Br J Dermatol. 2002;  146 928-929
  • 24 Friedman P M, Mafong E A, Kauvar A N, Geronemus R G. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation.  Dermatol Surg. 2002;  28 491-494
  • 25 Larsen N E, Pollak C T, Reiner K et al.. Hylan gel biomaterial: dermal and immunologic compatibility.  J Biomed Mater Res. 1993;  27 1129-1134
  • 26 Manna F, Dentini M, Desideri P et al.. Comparative chemical evaluation of two commercially available derivatives of hyaluronic acid (hylaform from rooster combs and restylane from streptococcus) used for soft tissue augmentation.  J Eur Acad Dermatol Venereol. 1999;  13 183-192
  • 27 Filion M C, Phillips N C. Pro-inflammatory activity of contaminating DNA in hyaluronic acid preparations.  J Pharm Pharmacol. 2001;  53 555-561
  • 28 Bergeret-Galley C, Latouche X, Illouz Y G. The value of a new filler material in corrective and cosmetic surgery: DermaLive and DermaDeep.  Aesthetic Plast Surg. 2001;  25 249-255

Raymond S DouglasM.D. 

Shorr-Douglas FACE Institute, 435 N. Roxbury

Suite 104, Beverly Hills, CA 90210

    >